SCHEMBL22908683

SCHEMBL22908683

COc1ccc(C2=NN(c3ccc(Cl)cc3Cl)C(=O)C2)cc1OC

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.58
MEN1 O00255 1/20 0.58
LMNA P02545 1/20 0.58
MAPT P10636 1/20 0.58
CD274 Q9NZQ7 4/20 0.57
PDCD1 Q15116 3/20 0.57
PDE4B Q07343 12/20 0.49
PDE4A P27815 3/20 0.49
PDE4C Q08493 3/20 0.49
PDE4D Q08499 3/20 0.49
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
CNR1 P21554 1/20 0.42
GAA P10253 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22908646 0.86 KMT2A (0.61) KMT2AMEN1LMNAMAPTCD274
SCHEMBL22908674 0.84 KMT2A (0.70) KMT2AMEN1LMNAMAPTCD274
SCHEMBL22908672 0.81 PDCD1 (0.58) KMT2AMEN1LMNAMAPTCD274
SCHEMBL10435326 0.79 MAPT (0.75) KMT2AMEN1LMNAMAPTCD274
SCHEMBL15057911 0.77 PDCD1 (0.60) CD274PDCD1PDE4BPDE4APDE4C
SCHEMBL15058050 0.77 PDE4B (0.79) KMT2AMEN1MAPTCD274PDCD1
SCHEMBL22908677 0.76 KMT2A (0.58) KMT2AMEN1LMNAMAPTCD274
SCHEMBL22908712 0.75 KMT2A (0.60) KMT2AMEN1LMNAMAPTCD274
SCHEMBL22909488 0.73 CD274 (1.00) CD274PDCD1PDE4BPDE4APDE4C
SCHEMBL10435333 0.73 MAPT (0.67) KMT2AMEN1LMNAMAPTCD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021009384-A1 NOVEL PYRAZOLONE DERIVATIVES AS PD-1/PD-L1 INTERACTION INHIBITORS CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE (FR) 2021-01-21 WO disclosed
EP-3766544-A1 NOVEL PYRAZOLONE DERIVATIVES AS PD-1/PD-L1 INTERACTION INHIBITORS Centre Hospitalier Regional Universitaire de Lille (FR) 2021-01-20 EP disclosed